IA
TTNP

IFP Advisors’s Titan Pharmaceuticals TTNP Stock Holding History

IFP Advisors’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$1K – 4367
2022
Q4 		$1K Sell
1
-41
-98% -$775 ﹤0.01% 4491
2022
Q3 		$3K Hold
42
– – ﹤0.01% 4270
2022
Q2 		$3K Hold
42
– – ﹤0.01% 4032
2022
Q1 		$3K Buy
+42
New +$873 ﹤0.01% 4032

Other funds holding TTNP

Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LFA
Level Financial Advisors East Amherst, New York $448M AUM 16.6% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IFP Advisors's TTNP Position: Q1 2023 in Review

IFP Advisors sold out of Titan Pharmaceuticals (TTNP) in Q1 2023, closing a stake of 1 share — an estimated $1K sold.

IFP Advisors first reported a position in TTNP in Q1 2022 and held it in 4 quarters. The position peaked at $3K in Q3 2022. 17 funds tracked by Wall St. Rank hold TTNP as of Q1 2023.

  • IFP Advisors reported no remaining Titan Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • IFP Advisors sold 1 Titan Pharmaceuticals share in Q1 2023, an estimated $1K.
  • IFP Advisors first reported a position in Titan Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • IFP Advisors's Titan Pharmaceuticals position peaked at $3K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2023.

Based on IFP Advisors's 13F filing for Q1 2023, filed 18 Apr 2023.